Clinical Trials Browser

Completed × Neuroinflammatory Diseases × 1 year × Clear all

Neuroinflammatory Diseases, Multiple Myeloma

NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Phase 4 Completed

56 enrolled

CNS

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Phase 2 Completed

18 enrolled

CNS

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

Clinical Trials

ZFAS1-BIPN

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent